One of the MassChallenge award wining company, Artiria, has just raised CHF 3.8 M to improve stroke treatments! This funding includes a CHF 2.7 M grant from the SERI-funded EIC accelerator grant. Together with this grant, the company secured a bridge financing of CHF 1.1 M with its current investors to further accelerate its clinical and regulatory deployment.
